Rx Name [FILGRASTIM, 1000]
|
|
ZARZIO 300MCG INJ (BCH/COL) FILGRASTIM
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
Prevention of neutropenia in patients receiving myelosup pressive cancer chemotherapy and to reduce the period of neutropenia in patients undergoing bone marrow transplantation
|
|
|
Musculoskeletal pain, dysuria
|
|
|
Adjunct to antineoplastic therapy, filgrastim is given in a dose of
5 micrograms/kg daily starting not less than 24 hours after t he last dose of antineop lastic. Bone marrow transp lantation is 10 micrograms/kg daily , adjusted according to response. |
|
|
|
|
|
Use only if potential benefit to mother justifies the risk to the fetus.
|
|
|
Use with caution for lactating women.
|
|
|
|